SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023455
Filing Date
2016-08-09
Accepted
2016-08-09 06:03:19
Documents
73
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-10q_20160630.htm 10-Q 1745106
2 EX-31.1 clvs-ex311_6.htm EX-31.1 16918
3 EX-31.2 clvs-ex312_7.htm EX-31.2 16818
4 EX-32.1 clvs-ex321_8.htm EX-32.1 4274
5 EX-32.2 clvs-ex322_9.htm EX-32.2 4559
  Complete submission text file 0001564590-16-023455.txt   6526114

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20160630.xml EX-101.INS 1459599
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20160630.xsd EX-101.SCH 45773
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20160630_cal.xml EX-101.CAL 46377
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20160630_def.xml EX-101.DEF 131678
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20160630_lab.xml EX-101.LAB 356151
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20160630_pre.xml EX-101.PRE 284393
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 161815921
SIC: 2834 Pharmaceutical Preparations